Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 114

Similar articles for PubMed (Select 23332770)

1.

Outcome of hepatocellular carcinoma in human immunodeficiency virus-infected patients.

Gramenzi A, Tedeschi S, Cantarini MC, Erroi V, Tumietto F, Attard L, Calza L, Foschi FG, Caraceni P, Pavoni M, Cucchetti A, Bernardi M, Viale P, Verucchi G, Trevisani F.

Dig Liver Dis. 2013 Jun;45(6):516-22. doi: 10.1016/j.dld.2012.12.010. Epub 2013 Jan 16.

PMID:
23332770
2.

The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.

Murillas J, Rimola A, Laguno M, de Lazzari E, Rascón J, Agüero F, Blanco JL, Moitinho E, Moreno A, Miró JM; ESLD-HIV Working Group Investigators.

Liver Transpl. 2009 Sep;15(9):1133-41. doi: 10.1002/lt.21735.

3.

Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a U.S.-Canadian multicenter study.

Bräu N, Fox RK, Xiao P, Marks K, Naqvi Z, Taylor LE, Trikha A, Sherman M, Sulkowski MS, Dieterich DT, Rigsby MO, Wright TL, Hernandez MD, Jain MK, Khatri GK, Sterling RK, Bonacini M, Martyn CA, Aytaman A, Llovet JM, Brown ST, Bini EJ; North American Liver Cancer in HIV Study Group.

J Hepatol. 2007 Oct;47(4):527-37. Epub 2007 Jul 19.

PMID:
17692986
4.

Liver transplantation for hepatocellular carcinoma: the impact of human immunodeficiency virus infection.

Vibert E, Duclos-Vallée JC, Ghigna MR, Hoti E, Salloum C, Guettier C, Castaing D, Samuel D, Adam R.

Hepatology. 2011 Feb;53(2):475-82. doi: 10.1002/hep.24062. Epub 2011 Jan 3.

PMID:
21274869
5.

Presentation, treatment, and clinical outcomes of patients with hepatocellular carcinoma, with and without human immunodeficiency virus infection.

Yopp AC, Subramanian M, Jain MK, Mansour JC, Schwarz RE, Balch GC, Singal AG.

Clin Gastroenterol Hepatol. 2012 Nov;10(11):1284-90. doi: 10.1016/j.cgh.2012.08.010. Epub 2012 Aug 16.

PMID:
22902759
6.
7.

Treatment and prognostic factors in patients with hepatocellular carcinoma.

Martins A, Cortez-Pinto H, Marques-Vidal P, Mendes N, Silva S, Fatela N, Glória H, Marinho R, Távora I, Ramalho F, de Moura MC.

Liver Int. 2006 Aug;26(6):680-7.

PMID:
16842324
8.

Use of antiviral therapy in surveillance: impact on outcome of hepatitis B-related hepatocellular carcinoma.

Chan SL, Mo FK, Wong VW, Liem GS, Wong GL, Chan VT, Poon DM, Loong HH, Yeo W, Chan AT, Mok TS, Chan HL.

Liver Int. 2012 Feb;32(2):271-8. doi: 10.1111/j.1478-3231.2011.02634.x. Epub 2011 Aug 31.

PMID:
22098536
9.

Do young hepatocellular carcinoma patients with relatively good liver function have poorer outcomes than elderly patients?

Cho SJ, Yoon JH, Hwang SS, Lee HS.

J Gastroenterol Hepatol. 2007 Aug;22(8):1226-31. Epub 2007 May 13.

PMID:
17498220
10.

High incidence of hepatocellular carcinoma in ESRD patients: caused by high hepatitis rate or 'uremia'? a population-based study.

Hwang JC, Weng SF, Weng RH.

Jpn J Clin Oncol. 2012 Sep;42(9):780-6. doi: 10.1093/jjco/hys100. Epub 2012 Jul 10.

11.

Prognostic factors after resection for hepatocellular carcinoma in nonfibrotic or moderately fibrotic liver. A 116-case European series.

Bège T, Le Treut YP, Hardwigsen J, Ananian P, Richa H, Campan P, Garcia S.

J Gastrointest Surg. 2007 May;11(5):619-25.

PMID:
17468920
12.

Characteristics and outcome of patients with dual hepatitis B and C-associated hepatocellular carcinoma: are they different from patients with single virus infection?

Huo TI, Huang YH, Hsia CY, Su CW, Lin HC, Hsu CY, Lee PC, Lui WY, Loong CC, Chiang JH, Chiou YY, Lee SD.

Liver Int. 2009 May;29(5):767-73. doi: 10.1111/j.1478-3231.2008.01908.x. Epub 2008 Nov 3.

PMID:
19018974
13.

Hepatocellular carcinoma in HIV-infected patients: check early, treat hard.

Berretta M, Garlassi E, Cacopardo B, Cappellani A, Guaraldi G, Cocchi S, De Paoli P, Lleshi A, Izzi I, Torresin A, Di Gangi P, Pietrangelo A, Ferrari M, Bearz A, Berretta S, Nasti G, Di Benedetto F, Balestreri L, Tirelli U, Ventura P.

Oncologist. 2011;16(9):1258-69. doi: 10.1634/theoncologist.2010-0400. Epub 2011 Aug 25.

14.

Hepatitis B or C virus serology as a prognostic factor in patients with hepatocellular carcinoma.

Ahmad SA, Bilimoria MM, Wang X, Izzo F, Delrio P, Marra P, Baker TP, Porter GA, Ellis LM, Vauthey JN, Dhamotharan S, Curley SA.

J Gastrointest Surg. 2001 Sep-Oct;5(5):468-76.

PMID:
11985997
15.

Comparison of prognosis by viral etiology in patients with hepatocellular carcinoma after radiofrequency ablation.

Chen PH, Kao WY, Chiou YY, Hung HH, Su CW, Chou YH, Huo TI, Huang YH, Wu WC, Chao Y, Lin HC, Wu JC.

Ann Hepatol. 2013 Mar-Apr;12(2):263-73.

PMID:
23396738
16.

Prognosis of hepatocellular carcinoma in anti-HCV positive cirrhotic patients: a single-centre comparison amongst four different staging systems.

Giannini E, Risso D, Botta F, Romagnoli P, Malfatti F, Fumagalli A, Testa E, Podestà E, Chiarbonello B, Polegato S, Testa R.

J Intern Med. 2004 Mar;255(3):399-408.

PMID:
14871465
17.

Long-term outcomes and prognostic factors of elderly patients with hepatocellular carcinoma undergoing hepatectomy.

Huang J, Li BK, Chen GH, Li JQ, Zhang YQ, Li GH, Yuan YF.

J Gastrointest Surg. 2009 Sep;13(9):1627-35. doi: 10.1007/s11605-009-0933-4. Epub 2009 Jun 9.

PMID:
19506976
18.

Comparison of the clinical characteristics among hepatocellular carcinoma of hepatitis B, hepatitis C and non-B non-C patients.

Dohmen K, Shigematsu H, Irie K, Ishibashi H.

Hepatogastroenterology. 2003 Nov-Dec;50(54):2022-7.

PMID:
14696457
19.

Mortality among human immunodeficiency virus-infected patients with cirrhosis or hepatocellular carcinoma due to hepatitis C virus in French Departments of Internal Medicine/Infectious Diseases, in 1995 and 1997.

Cacoub P, Geffray L, Rosenthal E, Perronne C, Veyssier P, Raguin G; Joint Study Group on Hepatitis C Virus of the French National Society of Internal Medicine and the French Society of Infectious Diseases (GERMVIC Study Group).

Clin Infect Dis. 2001 Apr 15;32(8):1207-14. Epub 2001 Mar 28.

20.

Surgical resection versus local ablation for HCC on cirrhosis: results from a propensity case-matched study.

Ruzzenente A, Guglielmi A, Sandri M, Campagnaro T, Valdegamberi A, Conci S, Bagante F, Turcato G, D'Onofrio M, Iacono C.

J Gastrointest Surg. 2012 Feb;16(2):301-11; discussion 311. doi: 10.1007/s11605-011-1745-x. Epub 2011 Nov 18.

PMID:
22095524
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk